Driving the Deal | Inside the 2025 Healthcare Market: A Conversation with J.P. Morgan
McDermott Will & Schulte Health Law Podcast
Release Date: 04/23/2025
Driving the Deal | Inside Europe’s Healthcare Landscape with Sharon Lamb
McDermott Will & Schulte Health Law Podcast
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Sharon Lamb, Head of McDermott’s UK Healthcare Practice Group. They unpack key themes from McDermott’s HPE Europe 2025 and explore the event’s biggest takeaways from shifting global policies on drug pricing and the boom in Chinese biotech, to AI’s growing role in R&D, supply chain dynamics, and the renewed investor focus on healthcare services heading into 2026. As they look ahead to the Jefferies Global Healthcare Conference in London next week, the conversation...
info_outline
Driving the Deal | Navigating OBBBA with General Atlantic’s Ben Wanamaker
McDermott Will & Schulte Health Law Podcast
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Ben Wanamaker, Operating Partner at General Atlantic to discuss how the One Big Beautiful Bill Act (OBBBA) is reshaping the Medicaid landscape. Ben breaks down OBBBA’s major provisions like work requirements, redeterminations, provider tax reductions, and cost-sharing rules and their implications for enrollment, member engagement, and provider payments. The conversation also explores: - How value-based care remains central to Medicaid innovation. - The importance of...
info_outline
Driving the Deal | What’s Next For Pharma with Cary Gibson
McDermott Will & Schulte Health Law Podcast
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Cary Gibson, founder of Gibson Health Policy and longtime Washington policy expert, to unpack the latest developments shaping the pharmaceutical landscape. From the Trump administration’s push to lower drug prices and the revival of “most favored nation” pricing concepts, to state-level prescription drug boards and 340B reform debates, Cary offers sharp insights on where the pressure points are and what’s next for the industry.
info_outline
Governing Health | Compensation considerations for health system innovation activities
McDermott Will & Schulte Health Law Podcast
This special series of the Governing Health podcast with SullivanCotter highlights developments in and offers support to the board’s executive compensation committee in light of the many complex operational, technical, and strategic issues that the committee confronts. In this episode, Michael Peregrine, Bruce Greenblatt, Kathy Hastings, John Collins, Kerrin Slattery, and Jeff Holdvogt discuss why innovative compensation incentives are a hot topic for health systems clients and their compensation committees.
info_outline
Driving the Deal | Compliance Strategies with Monica Wallace
McDermott Will & Schulte Health Law Podcast
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Monica Wallace, Partner at McDermott Will & Schulte and a leader of the firm’s Healthcare Regulatory & Compliance practice. Monica breaks down the rise in government healthcare audits, the use of extrapolated overpayments, and how providers can prepare. Together, they discuss avoiding overproduction of documents, getting legal and billing experts involved early, and acting quickly on audit letters to protect appeal rights. The episode also covers how audit history...
info_outline
Driving the Deal | AI’s Impact on RCM with White Plume’s Matt Menendez
McDermott Will & Schulte Health Law Podcast
On this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group, is joined by Matt Menendez, President of White Plume Technologies, to explore how AI is reshaping mid-revenue cycle management. They dive into trends in the PPM space, the rising importance of operational efficiency, and how AI is empowering coders with "superpowers" rather than replacing them. From silent revenue failures to front-end automation, learn how AI is driving real EBITDA gains per provider and what to expect in the years ahead.
info_outline
Driving the Deal | Rapid-Fire Medicaid Update Ahead of Senate Vote with Rodney Whitlock
McDermott Will & Schulte Health Law Podcast
In this episode of Driving the Deal, host Brian Fortune, Senior Managing Director at Farragut Square Group, is joined again by Rodney Whitlock, Vice President at McDermott+ and longtime Capitol Hill health policy expert for a rapid-fire Medicaid update recorded Friday, June 27. As the Senate eyes a final vote on the “One Big Beautiful Bill” Act (OBBBA), Rodney offers a real-time look at where things stood at the end of the week. They break down the Senate parliamentarian’s rulings striking several Medicaid provisions, including restrictions on eligibility and changes to provider taxes,...
info_outline
Driving the Deal | McDermott HealthEx Series: Evolving Landscape of PPMs
McDermott Will & Schulte Health Law Podcast
In our final episode of our McDermott HealthEx series, Brian Fortune, Senior Managing Director at Farragut Square Group, and Krist Werling, Partner & Global Head of Health & Life Sciences at McDermott Will & Emery, welcome Robbie Allen, CEO of US Heart & Vascular, for a candid conversation on the state of physician practice management. They explore the shifting dynamics of the PPM market, what it takes to build a truly integrated and high-performing platform, and how evolving physician expectations, new tech, and regulatory pressures are shaping the future of the space.
info_outline
Driving the Deal | McDermott HealthEx Series: Behavioral Health Deep Dive
McDermott Will & Schulte Health Law Podcast
In our third episode of our HealthEx series, live from the inaugural McDermott HealthEx conference in Nashville, TN, Brian Fortune, Senior Managing Director at Farragut Square Group, and Krist Werling, Partner & Global Head, Health & Life Sciences at McDermott Will & Emery, are joined by Gaurav Bhattacharyya, Chief Executive Officer of Geode Health, and Amanda Jester, Partner at McDermott Will & Emery. The group dives into the evolving behavioral health landscape, including consolidation trends, access and reimbursement challenges, workforce dynamics, and the future of...
info_outline
Driving the Deal | McDermott HealthEx Series: Opportunities in the Post-Acute Sector
McDermott Will & Schulte Health Law Podcast
We continue our HealthEx series, live from the inaugural McDermott HealthEx conference in Nashville, TN. On this episode, Brian Fortune, Senior Managing Director at Farragut Square Group sits down with Sarah Kitchell, Partner at McDermott Will & Emery, and Michael Zawadski, CEO of Collabrios Health, to explore trends and deal dynamics in the evolving post-acute care landscape. They discuss the resurgence of M&A activity, the impact of value-based care and Medicare Advantage, technology’s growing role, and the importance of scalable, integrated networks.
info_outlineIn this episode of Driving the Deal, Brian Fortune, Senior Managing Director at Farragut Square Group and Krist Werling, Partner & Global Head, Health & Life Sciences at McDermott Will & Emery are joined by three very special guests from J.P. Morgan, Matt Wedge, Managing Director & Co-Head of Middle Market Healthcare Investment Banking; Michael Smith, Executive Director; and Trey Hanlan, Managing Director. Together, they discuss signals shaping the healthcare investment landscape, from M&A momentum to sector hot spots, and share what they’re watching as we head into the 2025 J.P. Morgan Healthcare Leadership Summit in Nashville.